The Problem of TP53-Mutant MDS/AML
|
Sep 2020
|
Clinical Lymphoma , Myeloma & Leukemia
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria
|
Feb 2012
|
Am J Hum Genet
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
The Non-transplant Treatment of Myelodysplastic Syndromes-What's on the Horizon?
|
Oct 2012
|
Semin Hematol
|
myelodysplastic syndromes (MDS)
|
The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes
|
May 2019
|
Leukemia & Lymphoma
|
myelodysplastic syndromes (MDS)
|
The Myelodysplastic Syndromes: The Era Of Understanding
|
Sep 2014
|
Eur J Haematol
|
myelodysplastic syndromes (MDS)
|
The myelodysplastic syndromes flow cytometric score: a 3-parameter prognostic flow cytometric scoring system
|
Oct 2015
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
The Myelodysplastic Syndromes (MDS): A personal recollection of four decades of classification and prognostic scoring systems.
|
Apr 2013
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
The myelodysplastic syndrome as a prototypical epigenetic disease.
|
May 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
The mutational landscape of paroxysmal nocturnal hemoglobinuria revealed: new insights into clonal dominance
|
Sep 2014
|
J Clin Invest
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
The multifaceted nature of myelodysplastic syndromes: clinical, molecular, and biological prognostic features
|
Jul 2013
|
J Natl Compr Canc Netw
|
myelodysplastic syndromes (MDS)
|